BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20547844)

  • 1. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells.
    Suen DF; Narendra DP; Tanaka A; Manfredi G; Youle RJ
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11835-40. PubMed ID: 20547844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkin modulates heteroplasmy of truncated mtDNA in Caenorhabditis elegans.
    Valenci I; Yonai L; Bar-Yaacov D; Mishmar D; Ben-Zvi A
    Mitochondrion; 2015 Jan; 20():64-70. PubMed ID: 25462019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A yeast model of the neurogenic ataxia retinitis pigmentosa (NARP) T8993G mutation in the mitochondrial ATP synthase-6 gene.
    Rak M; Tetaud E; Duvezin-Caubet S; Ezkurdia N; Bietenhader M; Rytka J; di Rago JP
    J Biol Chem; 2007 Nov; 282(47):34039-47. PubMed ID: 17855363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioenergetics of mitochondrial diseases associated with mtDNA mutations.
    Lenaz G; Baracca A; Carelli V; D'Aurelio M; Sgarbi G; Solaini G
    Biochim Biophys Acta; 2004 Jul; 1658(1-2):89-94. PubMed ID: 15282179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondrial DNA mutation associated with the MELAS syndrome (mitochondrial encephalopathy, lactic acidosis, and strokelike episodes).
    Bakker A; Barthélémy C; Frachon P; Chateau D; Sternberg D; Mazat JP; Lombès A
    Pediatr Res; 2000 Aug; 48(2):143-50. PubMed ID: 10926287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Retinopathies.
    Zeviani M; Carelli V
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulating mitochondrial metabolite and ion transport has beneficial effects in yeast and human cellular models for NARP syndrome.
    Su X; Rak M; Tetaud E; Godard F; Sardin E; Bouhier M; Gombeau K; Caetano-Anollés D; Salin B; Chen H; di Rago JP; Tribouillard-Tanvier D
    Hum Mol Genet; 2019 Nov; 28(22):3792-3804. PubMed ID: 31276579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of common mitochondrial DNA mutations by allele-specific oligonucleotide and Southern blot hybridization.
    Tang S; Halberg MC; Floyd KC; Wang J
    Methods Mol Biol; 2012; 837():259-79. PubMed ID: 22215554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.
    Gammage PA; Rorbach J; Vincent AI; Rebar EJ; Minczuk M
    EMBO Mol Med; 2014 Apr; 6(4):458-66. PubMed ID: 24567072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of heteroplasmic mitochondrial DNA in single mitochondria.
    Reiner JE; Kishore RB; Levin BC; Albanetti T; Boire N; Knipe A; Helmerson K; Deckman KH
    PLoS One; 2010 Dec; 5(12):e14359. PubMed ID: 21179558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective elimination of mitochondrial mutations in the germline by genome editing.
    Reddy P; Ocampo A; Suzuki K; Luo J; Bacman SR; Williams SL; Sugawara A; Okamura D; Tsunekawa Y; Wu J; Lam D; Xiong X; Montserrat N; Esteban CR; Liu GH; Sancho-Martinez I; Manau D; Civico S; Cardellach F; Del Mar O'Callaghan M; Campistol J; Zhao H; Campistol JM; Moraes CT; Izpisua Belmonte JC
    Cell; 2015 Apr; 161(3):459-469. PubMed ID: 25910206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene.
    Kara B; Arıkan M; Maraş H; Abacı N; Cakıris A; Ustek D
    Mol Genet Metab; 2012 Nov; 107(3):389-93. PubMed ID: 22819295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.
    Tonin Y; Heckel AM; Vysokikh M; Dovydenko I; Meschaninova M; Rötig A; Munnich A; Venyaminova A; Tarassov I; Entelis N
    J Biol Chem; 2014 May; 289(19):13323-34. PubMed ID: 24692550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exome sequencing identified the mutation in YARS2 encoding the mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the phenotypic manifestation of Leber's hereditary optic neuropathy-associated mitochondrial DNA mutation.
    Jiang P; Jin X; Peng Y; Wang M; Liu H; Liu X; Zhang Z; Ji Y; Zhang J; Liang M; Zhao F; Sun YH; Zhang M; Zhou X; Chen Y; Mo JQ; Huang T; Qu J; Guan MX
    Hum Mol Genet; 2016 Feb; 25(3):584-96. PubMed ID: 26647310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases.
    Hashimoto M; Bacman SR; Peralta S; Falk MJ; Chomyn A; Chan DC; Williams SL; Moraes CT
    Mol Ther; 2015 Oct; 23(10):1592-9. PubMed ID: 26159306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
    Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
    Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair.
    Rothfuss O; Fischer H; Hasegawa T; Maisel M; Leitner P; Miesel F; Sharma M; Bornemann A; Berg D; Gasser T; Patenge N
    Hum Mol Genet; 2009 Oct; 18(20):3832-50. PubMed ID: 19617636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA.
    Matthews PM; Brown RM; Morten K; Marchington D; Poulton J; Brown G
    Hum Genet; 1995 Sep; 96(3):261-8. PubMed ID: 7649539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.